Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
about
Diabetes mellitus and burns. Part I-basic science and implications for managementAdrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humansGluconeogenesis from glutamine and lactate in the isolated human renal proximal tubule: longitudinal heterogeneity and lack of response to adrenalineRole of β-adrenergic receptors in regulation of hepatic fat accumulation during agingElevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms.β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.Insulin regulation of renal glucose metabolism in conscious dogs.Effect of infusing epinephrine on liver and muscle glycogenolysis during exercise in rats.Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans.Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used.Effects of alpha and beta adrenergic blockade on hepatic glucose balance before and after oral glucose. Role of insulin and glucagonBeta 1-selective and non-selective beta-adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.Role of hepatic autoregulation in defense against hypoglycemia in humans.Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epineMinimal changes in environmental temperature result in a significant increase in energy expenditure and changes in the hormonal homeostasis in healthy adults.Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal nAdrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.Normalized lactate load is associated with development of acute kidney injury in patients who underwent cardiopulmonary bypass surgeryA semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design.Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertensionAssessment of insulin action and glucose effectiveness in diabetic and nondiabetic humansEpinephrine deficiency results in intact glucose counter-regulation, severe hepatic steatosis and possible defective autophagy in fasting miceImportant genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats.Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome)An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.Mechanisms of epinephrine-induced glucose intolerance in normal humansRole of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker.Greater systemic lipolysis in women compared with men during moderate-dose infusion of epinephrine and/or norepinephrineExercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy.Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart FailureMechanism of glucoregulatory responses to stress and their deficiency in diabetes.Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies.Parenteral nutrition in patients with diabetes mellitus: theoretical and practical considerations.Pheochromocytoma with markedly abnormal liver function tests and severe leukocytosis.Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure.The biochemistry of diabetes.
P2860
Q28084664-5D87E6AE-5404-4CAC-AFD8-A498C3542802Q28343386-6106AD18-41C9-47E6-B3F8-502734490EAFQ28364596-68AE10A1-F5BA-47A2-9658-353FD3E360E6Q28572834-93B21DED-2F0B-4AFB-8FD0-EC287CB64AB2Q33847785-19376523-B2D4-4A74-8788-44BC37804938Q34019246-A12A0CD7-14B6-488F-B8D4-DA8126B7F029Q34152463-CDA8A8FF-E337-41C4-823C-DC44D3E9621CQ34181950-8075D169-6F2B-438B-88C6-19233B0EB3BEQ34221721-8B78A866-40DA-4E2E-9D4D-1F8CA8DFCB96Q34248284-8FC8900C-F22D-4EA1-80E1-907E1FE09BFBQ34519321-DB5FF316-9DA7-46DA-A4A6-07B40CCA6391Q34549728-04071250-B141-49E1-B9A1-3D9CD70A23CFQ34575386-5562FF12-E565-4CD3-A506-7880D306C3E9Q34622479-16E476A7-4866-411F-98BD-EB176946B588Q34627940-0A821562-174F-4935-BE96-2A854763D794Q34629732-CF37F2F0-7C36-404D-89FE-62706697FB2FQ35040889-D438853E-3B64-4741-BB87-00C475A1F5A8Q35208670-3B1E1666-028F-4791-AFEA-2D2869AF4192Q35208934-44087696-0B05-4F79-9025-A31F3D5F6FD6Q35231028-646FC0FD-7DDF-4832-B684-B66AC7AB73FFQ35318135-79488E1C-5703-45B6-8456-44CCDAFAD85AQ35603254-F77544B7-3A9C-44BB-9AE0-0EE0F48CF904Q35824548-2ABD8B37-FA87-494B-B224-0A7D252E53DAQ36455925-BFD35A06-9839-4E02-BEFA-CB2957B4F47BQ36761492-A7154666-579E-4F48-8AA1-274F36BC1F15Q36926325-31F0DE31-CF98-40B9-9E16-2FF27A44B971Q36992538-1A66A5F5-070A-428F-9019-07E1C68C91FCQ37004187-B37BA15E-3688-4B96-B700-E0590D855977Q37007264-AE60388D-5DF8-4260-9588-04D9A4E9C536Q37007413-B288428F-7DBA-4B60-824A-09D61669D2FEQ37233317-03D3DF2C-6128-42E6-9DBB-3350797D9E3FQ37264649-F99B9DA8-AC81-42D9-80D7-6C44250856A9Q37273001-376F384E-184C-4D8F-810B-58FAC1FA7DD2Q37299734-3849D2EC-77F1-4EF8-8175-49A1AD7A37DBQ37400941-3EF25F49-407F-4F54-B6D6-83C836E8FC31Q38178751-EB8B3BA6-FF2A-4DB8-8667-1092938F7368Q38241788-5B7943B4-0F1F-4E04-85D3-2A4A26D7A005Q38563595-244AFB65-0013-40F7-8856-4C1127845739Q38625516-B9D74FD4-B6ED-4206-A977-6D196CE35A82Q39650599-8ADD8F84-49DB-49C0-91AA-82BECAF4ECBE
P2860
Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1980
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adrenergic mechanisms for the ...... oduction and clearance in man.
@en
Adrenergic mechanisms for the ...... oduction and clearance in man.
@nl
type
label
Adrenergic mechanisms for the ...... oduction and clearance in man.
@en
Adrenergic mechanisms for the ...... oduction and clearance in man.
@nl
prefLabel
Adrenergic mechanisms for the ...... oduction and clearance in man.
@en
Adrenergic mechanisms for the ...... oduction and clearance in man.
@nl
P2093
P2860
P356
P1476
Adrenergic mechanisms for the ...... oduction and clearance in man.
@en
P2093
P2860
P304
P356
10.1172/JCI109714
P407
P577
1980-03-01T00:00:00Z